نتایج جستجو برای: like tyrosine kinase 3

تعداد نتایج: 2524300  

Hossein Ayatollahi, Hossein Rahimi, Mohammad Hadi Sadeghian, Mohammad Mehdi Kooshyar, Mohammad Reza Keramati, Sepideh Shakeri, Seyyede Fatemeh Shams,

Background and Aims: Multiple myeloma is a malignant proliferation of plasma cells derived from a single clone. The tumor, its products and the host response lead to organ damages. Some factors that are responsible in its pathogenesis are recognized. As FMS like Tyrosine Kinase 3 receptor (FLT3) mutation has been proved as a determining factor in leukemic patients the goal of this study was to ...

Journal: :iranian journal of pharmacology and therapeutics 0
ashish kumar rehni nirmal singh seema jindal

suppression of akt (protein kinase b) has been implicated in schizophrenia, the effect which has been documented to be reversed by tyrosine phosphatase inhibition. t hus, present study has been designed to study the effect of sodium orthovanadate, a tyrosine phosphatase inhibitor, on protracted methionine administration induced schizophrenia like behavior in rats.   schizophrenia like behavior ...

Journal: :مجله پزشکی مولکولی 0
soheila moein , molecular medicine research center , faculty of medicine

introduction: atherosclerosis, hypertension, ischemic diseases, alzheimer’s disease, parkinson disease, cancer and inflammation emerge from imbalance between antioxidant and oxidants. cancer is a most important public health problem in both developed and developing countries. natural antioxidants such as polyphenols are being used for prevention and treatment cancer. polyphenols include phenoli...

Journal: :Archives of Iranian medicine 2010
Farhad Zaker Mohammad Mohammadzadeh Mohammad Mohammadi

BACKGROUND Mutations in KIT and fms-like tyrosine kinase 3 genes lead to uncontrolled proliferation of leukemic cells with a poor prognosis. Since, data concerning the incidence and associations with patients characteristics vary amongst different studies, the aim of the present study is to identify and quantify the frequency of mutations in Iranian patients suffering from acute myeloid leukemi...

Journal: :Blood 2010
Thomas Kindler Daniel B Lipka Thomas Fischer

Mutations within the FMS-like tyrosine kinase 3 (FLT3) gene on chromosome 13q12 have been detected in up to 35% of acute myeloid leukemia (AML) patients and represent one of the most frequently identified genetic alterations in AML. Over the last years, FLT3 has emerged as a promising molecular target in therapy of AML. Here, we review results of clinical trials and of correlative laboratory st...

Journal: :international journal of hematology-oncology and stem cell research 0
franceli carvalho joice zuckermann alessandra paz gustavo fischer liane esteves daudt lisandra della costa rigoni

introduction: tyrosine kinase inhibitors (tkis) were the first drugs to use an intracellular signaling molecule as a therapeutic target. unresponsiveness to tkis limits therapeutic options, making allogeneic hematopoietic stem cell transplantation (hsct) the only option leading to molecular remission. objectives: to characterize cml patients unresponsive to first- and/or second-generation tki t...

Journal: :iranian journal of radiation research 0
a. gaur l.b.s. college of pharmacy, jaipur-302004, rajasthan, india

background: genistein is a soya isoflavone, which is found naturally in legumes, such as soybeans and chickpeas. radiation–induced free radicals in turn impair the antioxidative defense mechanism, leading to an increased membrane lipid peroxidation that results in damage of the membrane bound enzyme and may lead to damage or death of cell. hence, the lipid peroxidation is a good biomarker of da...

Journal: :international journal of hematology-oncology and stem cell research 0
marjan yaghmaie medical genetics department, faculty of medical sciences, tarbiat modares university, tehran, iran hossein mozdarani medical genetics department, faculty of medical sciences, tarbiat modares university, tehran, iran kamran alimoghaddam hematology, oncology and stem cell transplantation research center, shariati hospital, tehran university, tehran, iran ardeshir ghavamzadeh hematology, oncology and stem cell transplantation research center, shariati hospital, tehran university, tehran, iran seyed hamiollah ghaffari hematology, oncology and stem cell transplantation research center, shariati hospital, tehran university, tehran, iran

introduction: the secondary genetic changes other than the pml-rara fusion gene may contribute to the acute promyelocytic leukemogenesis. chromosomal alterations and mutation of flt3 tyrosine kinase receptor are the frequent genetic alterations in acute myeloid leukemia (aml). however, the prognostic significance of flt3 mutations in acute promyelocytic leukemia (apl) is not firmly established....

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید